(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 8.93%2.65B | 0.96%5.13B | -0.28%2.44B | 15.15%5.09B | 24.06%2.44B | 13.20%4.42B | 3.50%1.97B | -0.63%3.9B | 13.17%1.9B | 22.81%3.93B |
Operating income | 8.93%2.65B | 0.96%5.13B | -0.28%2.44B | 15.15%5.09B | 24.06%2.44B | 13.20%4.42B | 3.50%1.97B | -0.63%3.9B | 13.17%1.9B | 22.81%3.93B |
Cost of sales | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -15.86%-3.5B |
Operating expenses | -12.18%-2.42B | -0.90%-4.54B | 3.00%-2.15B | -16.68%-4.5B | -24.05%-2.22B | -16.99%-3.86B | -17.89%-1.79B | 5.70%-3.3B | 1.03%-1.52B | -15.86%-3.5B |
Gross profit | -15.88%237.41M | 1.37%591.46M | 26.94%282.23M | 4.58%583.5M | 24.11%222.34M | -7.51%557.94M | -53.37%179.14M | 40.81%603.25M | 161.55%384.14M | 140.68%428.42M |
Selling expenses | 6.78%-79.02M | 52.53%-156.27M | 51.01%-84.77M | 4.58%-329.21M | -6.29%-173.02M | -50.00%-345.02M | -34.46%-162.77M | -44.39%-230.01M | -94.39%-121.06M | -32.29%-159.29M |
Administrative expenses | -17.11%-61.94M | 7.28%-100.6M | -9.89%-52.89M | -21.49%-108.5M | 4.11%-48.13M | 21.65%-89.31M | -16.09%-50.2M | 29.03%-113.99M | 30.50%-43.24M | -19.25%-160.63M |
Research and development expenses | 6.30%-12.31M | 28.91%-22.71M | 15.05%-13.14M | -27.86%-31.94M | -23.77%-15.47M | -16.75%-24.98M | -27.94%-12.5M | ---21.4M | -23.28%-9.77M | ---- |
Profit from asset sales | 100.46%11K | -67.37%248.47K | -1,320.71%-2.42M | -53.05%761.37K | --198K | 6.50%1.62M | ---- | --1.52M | ---- | ---- |
Revaluation surplus | -113.77%-1.42M | -86.77%2.87M | 202.86%10.3M | 620.25%21.69M | 2.05%-10.02M | 84.65%-4.17M | ---10.23M | ---27.16M | ---- | ---- |
-Changes in the fair value of other assets | -113.77%-1.42M | -86.77%2.87M | 202.86%10.3M | 620.25%21.69M | 2.05%-10.02M | 84.65%-4.17M | ---10.23M | ---27.16M | ---- | ---- |
Impairment and provision | -8,571.05%-6.44M | 99.07%-7.62M | 20.63%76K | -37,790.41%-814.8M | 117.60%63K | -171.29%-2.15M | -169.17%-358K | 504.87%3.02M | 80.75%-133K | 71.77%-745K |
-Other impairment is provision | -8,571.05%-6.44M | 99.07%-7.62M | 20.63%76K | -37,790.41%-814.8M | 117.60%63K | -171.29%-2.15M | -169.17%-358K | 504.87%3.02M | 80.75%-133K | 71.77%-745K |
Operating interest expense | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---89.32M |
Special items of operating profit | -158.17%-1.68M | 200.06%1.47M | 666.01%2.88M | -104.55%-1.47M | -102.16%-509K | 10.01%32.18M | 1,388.99%23.54M | -96.43%29.26M | -99.58%1.58M | 161.11%820.29M |
Operating profit | -54.89%56.36M | 137.97%273.02M | 387.55%124.95M | -844.73%-719.11M | 8.50%-43.45M | -55.72%96.56M | -123.83%-47.49M | -74.00%218.07M | -48.74%199.28M | 257.80%838.72M |
Financing cost | 22.35%-32.36M | -109.72%-102.98M | -76.92%-41.67M | -2.95%-49.1M | -75.79%-23.55M | 10.06%-47.7M | 54.43%-13.4M | ---53.03M | 38.28%-29.4M | ---- |
Special items of earning before tax | -786.29%-3.05M | -15,230.25%-6.09M | 78.71%445K | 66.91%-39.72K | -86.37%249K | 98.40%-120.05K | 123.00%1.83M | ---7.48M | ---7.94M | ---- |
Adjustment items of earning before tax | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1K | ---- |
Earning before tax | -74.98%20.95M | 121.34%163.94M | 225.42%83.73M | -1,676.10%-768.26M | -13.03%-66.75M | -69.06%48.74M | -136.47%-59.06M | -81.21%157.56M | -52.53%161.94M | 510.36%838.72M |
Tax | 2,500.00%39.14M | -392.46%-3.63M | 61.02%-1.63M | 55.87%-736.32K | -386.97%-4.18M | 71.94%-1.67M | 255.11%1.46M | -344.47%-5.95M | -78.37%-940K | -66.63%-1.34M |
After-tax profit from continuing operations | -26.80%60.09M | 120.85%160.32M | 215.73%82.1M | -1,733.54%-768.99M | -23.15%-70.94M | -68.95%47.08M | -135.78%-57.6M | -81.89%151.62M | -52.73%161M | 512.97%837.38M |
Special items of earning after tax | ---- | ---- | ---- | ---- | ---1K | ---- | ---- | ---- | ---- | ---- |
Adjustment items of earning after tax | ---- | ---- | ---- | ---- | --1K | ---- | ---- | ---- | ---- | ---- |
Earning after tax | -26.80%60.09M | 120.85%160.32M | 215.73%82.1M | -1,733.54%-768.99M | -23.15%-70.94M | -68.95%47.08M | -135.78%-57.6M | -81.89%151.62M | -52.73%161M | 512.97%837.38M |
Minority profit | ---- | ---- | ---- | ---- | ---- | -274.20%-3.84M | -74.13%-653K | -626.89%-1.02M | -156.85%-375K | 96.26%-141K |
Adjustment items of profit attributable to shareholders | ---- | ---- | ---- | ---- | ---- | ---- | 470,700.00%4.71M | ---- | ---1K | ---- |
Profit attributable to shareholders | -26.80%60.09M | 120.85%160.32M | 215.73%82.1M | -1,610.48%-768.99M | -15.05%-70.94M | -66.65%50.91M | -138.21%-61.66M | -81.77%152.64M | -52.64%161.38M | 496.60%837.52M |
Basic earnings per share | -33.33%0.04 | 120.00%0.11 | 220.00%0.06 | -1,475.00%-0.55 | -25.00%-0.05 | -69.23%0.04 | -126.67%-0.04 | -83.78%0.13 | -54.00%0.15 | 496.80%0.8015 |
Diluted earnings per share | -33.33%0.04 | 120.00%0.11 | 220.00%0.06 | -1,475.00%-0.55 | -25.00%-0.05 | -69.23%0.04 | -126.67%-0.04 | -83.78%0.13 | -54.00%0.15 | 496.80%0.8015 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | IAS |
Audit Opinions | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | Lixin Certified Public Accountants | -- | Lixin Certified Public Accountants | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data